过去一年中添加的文章,按日期排序

Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: a 6-year follow-up.

X Ayrignac, S Aouinti, T Vincent… - Multiple Sclerosis and …, 2024 - Elsevier
4 天前 - Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) are
promising biomarkers that might be associated with clinical and … glial fibrillary acidic protein

Admission levels of serum biomarkers have additive and cumulative prognostic value in traumatic brain injury

IA Kaaber, M Lesbo, TO Wichmann, DA Olsen… - Scientific Reports, 2024 - nature.com
9 天前 - … the value of adding acute serum biomarker levels to common clinical outcome …
serum samples for Total-Tau (T-Tau), Neurofilament light chain (Nfl), Glial fibrillary acidic protein (…

Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Promising Screening Biomarkers for Brain Metastases in Patients with Lung Cancer

SH Kim, BC Ahn, DE Lee, KH Kim, JW Hyun… - International Journal of …, 2024 - mdpi.com
18 天前 - … This study explores the potential of serum neurofilament light chain (sNfL) and
serum glial fibrillary acidic protein (sGFAP) as screening biomarkers for BMs in LC patients. We …

Seizures may worsen outcomes of neonatal hypoxic ischemic encephalopathy: a longitudinal serum biomarkers study

KB Aziz, J Kuiper, A Kilborn, H Kambli, S Jayakumar… - medRxiv, 2024 - medrxiv.org
38 天前 - … who had sufficient remnant serum for biomarker analysis. Neonates … glial fibrillary
acidic protein (GFAP, astrocytic reactivity), Tau (neuronal injury) and neurofilament light chain

Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled …

R Zivadinov, D Jakimovski, A Burnham, J Kuhle… - Journal of …, 2024 - Springer
42 天前 - … their associations with neuroimaging and serum biomarkers, are subject of separate
… where serum neurofilament light chain (sNfL) [21] and serum glial acidic fibrillar protein

Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid‐refractory multiple sclerosis relapses

I Vardakas, J Dorst, A Huss, B Mayer… - European Journal of …, 2024 - Wiley Online Library
56 天前 - Serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP)
are biomarkers that are associated with ongoing inflammatory activity and MS- related …

Elevated Serum Neurologic Biomarker Profiles after Cardiac Arrest in a Porcine Model

K Senthil, A Ranganathan, S Piel, MM Hefti… - Available at SSRN … - papers.ssrn.com
57 天前 - … Plasma neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), and
cytokine … following ROSC for neurofilament light chain (NfL), glial fibrillary acid protein (GFAP), …

[HTML][HTML] Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis

K Koerbel, M Maiworm, M Schaller-Paule… - Multiple Sclerosis and …, 2024 - Elsevier
63 天前 - … of neurofilament light chain (NfL), glial fibrillary acidic … performed for each serum/CSF
biomarker concentration to … Among them, glial fibrillary acidic protein (GFAP) is known to …

Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer's disease

X Wang, X Zhang, J Liu, J Zhang, C Liu, Y Cui… - Alzheimer's Research & …, 2024 - Springer
76 天前 - serum SV2A, glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL)
and p-tau217 testing; 92 subjects including aMCI and AD underwent both CSF SV2A and …

Racial discrimination during middle age predicts higher serum phosphorylated tau and neurofilament light chain levels a decade later: A study of aging black …

RL Simons, ML Ong, MK Lei, SRH Beach… - Alzheimer's & …, 2024 - Wiley Online Library
79 天前 - … ) biomarkers: serum phosphorylated tau181(p-tau181), neurofilament light (NfL), and
glial fibrillary acidic protein … these serum biomarkers as the participants aged into their 60s. …